Treatment group:Drug intervention

Clinical Study on the Efficacy and Safety of Disitamab Vedotin Combined With Toripalimab and FOLFOX4 in the perioperative treatment of locally advanced gastric cancer with HER2 expression

A study on the efficacy and safety of Toripalimab combined with Regorafenib in the second-line and subsequent treatment of hepatocellular carcinoma previously treated with immunotherapy